Congrats @anzuptrials.bsky.social #ENZAp study +ve OS & QoL results presented by Prof Emmett @ascocancer.bsky.social #GU25 & in @thelancet.bsky.social #Movember #CancerAustralia #Astellas #ARTnet #StVincentsClinic #RoyMorgan #Novartis #MimSoftware #GenesisCare #ANSTO #NHMRCCTC @profiand.bsky.social
Beautiful presentation by Prof Louise Emmett of the @anzuptrials.bsky.social #ENZAp trial of enzalutamide +/- LuPSMA:
✅ Improved OS
✅ Improved quality of life
Published today in Lancet Oncology www.thelancet.com/journals/lan...
✅ Improved OS
✅ Improved quality of life
Published today in Lancet Oncology www.thelancet.com/journals/lan...
February 13, 2025 at 8:20 PM
Congrats @anzuptrials.bsky.social #ENZAp study +ve OS & QoL results presented by Prof Emmett @ascocancer.bsky.social #GU25 & in @thelancet.bsky.social #Movember #CancerAustralia #Astellas #ARTnet #StVincentsClinic #RoyMorgan #Novartis #MimSoftware #GenesisCare #ANSTO #NHMRCCTC @profiand.bsky.social
Congrats @anzuptrials.bsky.social #TheraP study presented #ASCO25 by #AslıMunzur #PCF #BCCancerFoundation @terryfoxfoundation.bsky.social #CanadianCancerSociety @petermaccc.bsky.social #VancouverPC #VCHResearchInstitute #UBC #PCFA #Movember @ansto.bsky.social #NHMRCCTC #GentlemansRide #Novartis
June 2, 2025 at 4:36 AM
Great to see @anzuptrials.bsky.social #P3BEP poster @ascocancer.bsky.social #GU25 presented by @martinstockler.bsky.social pictured with #CancerResearch pioneer #LarryEinhorn. Congrats #PeterGrimison & #P3BEP team @cancerresearchuk.org @cuhnhs.bsky.social #ANZCHOG #Children’sOncologyGroup #NHMRCCTC
February 16, 2025 at 1:37 AM
Great to see @anzuptrials.bsky.social #P3BEP poster @ascocancer.bsky.social #GU25 presented by @martinstockler.bsky.social pictured with #CancerResearch pioneer #LarryEinhorn. Congrats #PeterGrimison & #P3BEP team @cancerresearchuk.org @cuhnhs.bsky.social #ANZCHOG #Children’sOncologyGroup #NHMRCCTC
Congrats to our @anzuptrials.bsky.social #EVOLUTIONtrial for on their oral presentation by Prof Shahneen Sandhu at #ASCO25. This Phase 2 #ProstateCancer trial is supported by #PCFA and collaborators #NHMRCCTC #BMS @novartis.bsky.social. Thanks Study Co-Chair Prof Louise Emmett @profiand.bsky.social
June 2, 2025 at 3:59 AM
Congrats to our @anzuptrials.bsky.social #EVOLUTIONtrial for on their oral presentation by Prof Shahneen Sandhu at #ASCO25. This Phase 2 #ProstateCancer trial is supported by #PCFA and collaborators #NHMRCCTC #BMS @novartis.bsky.social. Thanks Study Co-Chair Prof Louise Emmett @profiand.bsky.social
Great to see @anzuptrials.bsky.social #ENZAMET study feature in 2 more posters #ASCO25 by Prof Louise Emmett and Prof Lisa Horvath (pictured with co-author Prof Anthony Joshua) #ChrisSweeney @profiand.bsky.social #NHMRCCTC @cancertrialsie.bsky.social @cctg.bsky.social @astellaspharma.bsky.social
June 3, 2025 at 7:48 AM
Great to see @anzuptrials.bsky.social #ENZAMET study feature in 2 more posters #ASCO25 by Prof Louise Emmett and Prof Lisa Horvath (pictured with co-author Prof Anthony Joshua) #ChrisSweeney @profiand.bsky.social #NHMRCCTC @cancertrialsie.bsky.social @cctg.bsky.social @astellaspharma.bsky.social
Well done! The @anzuptrials.bsky.social #BCGMM trial has been presented at #ASCO25 showing BCG plus mitomycin a safe & effective alternative to BCG alone & the added benefit of requiring 40% fewer BCG doses. Congrats to Prof Dickon Hayne & team #NHMRCCTC @profiand.bsky.social #MSDAus #OmegaPharm
June 2, 2025 at 3:07 AM
Well done! The @anzuptrials.bsky.social #BCGMM trial has been presented at #ASCO25 showing BCG plus mitomycin a safe & effective alternative to BCG alone & the added benefit of requiring 40% fewer BCG doses. Congrats to Prof Dickon Hayne & team #NHMRCCTC @profiand.bsky.social #MSDAus #OmegaPharm
Congrats @anzuptrials.bsky.social #ENZAp study oral presentation by Prof Emmett @ascocancer.bsky.social #ASCO25 #Movember #CancerAustralia #Astellas #ARTnet #StVincentsClinic #RoyMorgan #Novartis #MimSoftware #GenesisCare #ANSTO #NHMRCCTC @profiand.bsky.social
June 3, 2025 at 12:20 AM
Congrats @anzuptrials.bsky.social #ENZAp study oral presentation by Prof Emmett @ascocancer.bsky.social #ASCO25 #Movember #CancerAustralia #Astellas #ARTnet #StVincentsClinic #RoyMorgan #Novartis #MimSoftware #GenesisCare #ANSTO #NHMRCCTC @profiand.bsky.social
Great to see @anzuptrials.bsky.social #ENZAMET study feature in two Plain Language Summaries this month: bit.ly/4jpkxeh & bit.ly/40qTC9e #ProfChristopherSweeney @profiand.bsky.social #NHMRCCTC @cancertrialsie.bsky.social @cctg.bsky.social @astellaspharma.bsky.social #CancerAustralia
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)
Published in Future Oncology (Ahead of Print, 2025)
bit.ly
January 23, 2025 at 3:06 AM
Great to see @anzuptrials.bsky.social #ENZAMET study feature in two Plain Language Summaries this month: bit.ly/4jpkxeh & bit.ly/40qTC9e #ProfChristopherSweeney @profiand.bsky.social #NHMRCCTC @cancertrialsie.bsky.social @cctg.bsky.social @astellaspharma.bsky.social #CancerAustralia
Great to see @anzuptrials.bsky.social #ENZAMET 8-year outcomes poster feature at #ASCO25 presented by Alison Zhang #ChrisSweeney @profiand.bsky.social #NHMRCCTC @cancertrialsie.bsky.social @cctg.bsky.social @astellaspharma.bsky.social #CancerAustralia
June 2, 2025 at 11:10 PM
Great to see @anzuptrials.bsky.social #ENZAMET 8-year outcomes poster feature at #ASCO25 presented by Alison Zhang #ChrisSweeney @profiand.bsky.social #NHMRCCTC @cancertrialsie.bsky.social @cctg.bsky.social @astellaspharma.bsky.social #CancerAustralia
Congrats @anzuptrials.bsky.social #ENZAp @thelancetoncol.bsky.social publication by Prof Emmett @ascocancer.bsky.social #Movember #CancerAustralia #Astellas #ARTnet #StVincentsClinic #RoyMorgan #Novartis #MimSoftware #GenesisCare #ANSTO #NHMRCCTC @profiand.bsky.social
anzup.org.au/wp-content/u...
anzup.org.au/wp-content/u...
July 31, 2025 at 1:43 AM